Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRDX
3601
DELISTED
Surmodics
SRDX
| $687K | ﹤0.01% |
18,909
+16,492
| +682% | +$540K |
|
3602
Oil-Dri
ODC
$1.34B
| $686K | ﹤0.01% |
20,468
+10,554
| +106% | +$320K |
|
|
AMPS
3603
DELISTED
Altus Power
AMPS
| $686K | ﹤0.01% |
100,483
+77,726
| +342% | +$421K |
|
|
AMNB
3604
DELISTED
American National Bankshares Inc
AMNB
| $686K | ﹤0.01% |
14,064
+12,300
| +697% | +$515K |
|
3605
Entravision Communication
EVC
$1.1B
| $683K | ﹤0.01% |
163,866
+82,150
| +101% | +$325K |
|
3606
BayCom
BCML
$333M
| $683K | ﹤0.01% |
28,932
+13,303
| +85% | +$279K |
|
|
STER
3607
DELISTED
Sterling Check Corp. Common Stock
STER
| $679K | ﹤0.01% |
48,795
+38,829
| +390% | +$488K |
|
3608
Anterix
ATEX
$1.94B
| $677K | ﹤0.01% |
20,330
+15,680
| +337% | +$506K |
|
|
VRN
3609
DELISTED
Veren
VRN
| $675K | ﹤0.01% |
97,392
-1,739
| -2% | -$12.8K |
|
|
SRTA
3610
Strata Critical Medical Inc
SRTA
$512M
| $675K | ﹤0.01% |
191,175
+54,864
| +40% | +$157K |
|
3611
Phinia Inc
PHIN
$2.74B
| $674K | ﹤0.01% |
22,250
-305,202
| -93% | -$8.19M |
|
3612
Boston Omaha
BOC
$436M
| $673K | ﹤0.01% |
+42,765
| New | +$649K |
|
3613
GrafTech
EAF
$212M
| $672K | ﹤0.01% |
30,681
+23,518
| +328% | +$665K |
|
3614
AST SpaceMobile
ASTS
$21.5B
| $666K | ﹤0.01% |
110,411
+96,203
| +677% | +$417K |
|
3615
Bowman Consulting
BWMN
$477M
| $665K | ﹤0.01% |
18,719
+13,834
| +283% | +$413K |
|
3616
ALX Oncology
ALXO
$290M
| $665K | ﹤0.01% |
44,637
+17,673
| +66% | +$168K |
|
3617
Costamare
CMRE
$1.77B
| $664K | ﹤0.01% |
63,774
+55,311
| +654% | +$527K |
|
3618
Wheels Up
UP
$198M
| $659K | ﹤0.01% |
+9,600
| New | +$372K |
|
3619
ATS Corp
ATS
$2.05B
| $658K | ﹤0.01% |
15,269
-101
| -0.7% | -$3.92K |
|
3620
Nature's Sunshine
NATR
$288M
| $657K | ﹤0.01% |
38,022
+16,799
| +79% | +$290K |
|
3621
Codexis
CDXS
$158M
| $657K | ﹤0.01% |
215,427
+60,372
| +39% | +$130K |
|
|
EVBN
3622
DELISTED
Evans Bancorp Inc
EVBN
| $655K | ﹤0.01% |
20,782
+6,229
| +43% | +$174K |
|
3623
Urban One Class A
UONE
$23.8M
| $655K | ﹤0.01% |
16,252
-6,003
| -27% | -$281K |
|
|
EBTC
3624
DELISTED
Enterprise Bancorp
EBTC
| $655K | ﹤0.01% |
20,292
+12,091
| +147% | +$340K |
|
3625
Jakks Pacific
JAKK
$293M
| $652K | ﹤0.01% |
18,350
+7,865
| +75% | +$203K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.